Also supporting our findings, Yamada et al. examined the association between the SOD3 R213G variant and mortality in 456 hemodialysis patients, of which 87 had diabetes, and found a higher mortality in R213G heterozygote diabetic subjects than in non-carriers (Yamada et al., 2000). This evidence concerns the gene SOD3 and diabetes mellitus.